You are here

Press Releases

Press Release | January 8, 2020

WASHINGTON, D.C. - Today, the Advanced Medical Technology Association (AdvaMed) announced that AdvaMed President and CEO Scott Whitaker signed the CEO Action for Diversity and Inclusion pledge, the largest CEO-driven business commitment to advance diversity and inclusion within the workplace: "We believe the medical technology industry should be an industry of choice for people of all backgrounds."

Press Release | December 20, 2019

WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) issued the following statement from President and CEO Scott Whitaker on President Trump's signing of legislation to repeal the medical device excise tax:  

Press Release | December 19, 2019

WASHINGTON, D.C. – AdvaMed President and CEO Scott Whitaker and AdvaMedDx Executive Director Susan Van Meter issued the following statements upon congressional passage of the Laboratory Access for Beneficiaries (LAB) Act as part of the broader government funding agreement expected to be signed into law this week by President Trump:

Press Release | December 19, 2019
Mark Brager
mbrager@advamed.org

WASHINGTON, D.C. – AdvaMed President and CEO Scott Whitaker today released the following statement on Senate passage of full repeal of the medical device excise tax:

“On behalf of the entire medtech industry and the patients we serve, we thank the Senate for passing legislation to repeal the medical device excise tax once and for all. Without the leadership of Majority Leader Mitch McConnell and Minority Leader Chuck Schumer, as well as that of Sen. Pat Toomey and all the cosponsors of the device tax repeal legislation, the industry would be facing massive job losses and cuts to the very research and development we need to save and improve patients’ lives. Patients are the real winners here today.

“We look forward to the president signing this legislation into law.”

# # #

AdvaMed member companies produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. AdvaMed members range from the largest to the smallest medical technology innovators and companies. For more information, visit www.advamed.org.

Press Release | December 17, 2019

WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) issued the following statement from President and CEO Scott Whitaker on the U.S. House of Representatives’ vote to repeal the medical device excise tax:

Press Release | December 16, 2019

WASHINGTON, D.C. – AdvaMed President and CEO Scott Whitaker released the following statement on the announcement by congressional leadership of a funding agreement that includes full repeal of the medical device excise tax. The agreement is expected to be passed this week by Congress and signed into law by President Trump:

Press Release | December 13, 2019

WASHINGTON, D.C. – In an op-ed published today in Morning Consult, AdvaMed President and CEO Scott Whitaker urges Congress to act before the medical device excise tax comes back into effect Jan. 1.

Press Release | December 12, 2019

WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) issued the following statement today from President and CEO Scott Whitaker regarding the U.S. Senate’s confirmation of Dr. Stephen Hahn to serve as the new FDA Commissioner:

“Dr. Hahn is an excellent choice to lead FDA, and we congratulate him on his swift and overwhelming bipartisan confirmation. During the confirmation process, Dr. Hahn demonstrated his deep understanding of the agency’s mission to protect and promote the public health and the role of innovation in improving patient care. His background as a physician, researcher and administrator will serve the American people well at this vital agency. We look forward to working with him on behalf of the patients our industry serves.”

Press Release | December 12, 2019

WASHINGTON, D.C. – In today’s Wall Street Journal, the editorial board wrote that Congress “should stop a return of the destructive” medical device excise tax scheduled to go into effect on Jan. 1.

Press Release | December 11, 2019

WASHINGTON, D.C. – More than half of medical device company employees expect reinstatement of the medical device excise tax in 2020 to lead both to job losses and cuts to research and development programs, according to a new survey by a top industry and business news publisher, SmartBrief.

Pages